Tue, 14 Aug 2018 14:23:37: AIDS health group brings Gilead patent skirmish to Supreme Court

Tue, 14 Aug 2018 13:59:59: Pfizer joins DOJ probe into claims pharma bribes funded Iraqi terrorists

Tue, 14 Aug 2018 13:59:07: Allergan taps Pfizer oncology veteran as CMO for some crucial pipeline help

Mon, 13 Aug 2018 20:09:54: NICE cost watchdogs spurn Biogen's pricey Spinraza but leave door open for a deal

Mon, 13 Aug 2018 19:35:22: Bavarian Nordic secures €30M loan as it expands plant to bring Imvamune manufacturing entirely in-house

Mon, 13 Aug 2018 15:28:30: Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies

Mon, 13 Aug 2018 14:05:01: CVS' move to lean on ICER data could mean dramatic shift in drug pricing leverage

Mon, 13 Aug 2018 13:42:17: Alnylam vows value-based pricing, financial help with $450K Onpattro launch

Mon, 13 Aug 2018 11:57:54: J&J loses early bid to escape Pfizer's Remicade biosimilars lawsuit

Sat, 11 Aug 2018 22:13:40: Outcome's image rehab rolls on with Nielsen deal for first-ever POC audience tallies

Sat, 11 Aug 2018 16:13:39: Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra

Fri, 10 Aug 2018 15:26:23: FDA found big problems a year ago at Chinese plant now recalling tainted valsartan

Fri, 10 Aug 2018 15:05:42: States say Alvogen lawsuit is part of a 'guerilla' war against the death penalty

Fri, 10 Aug 2018 14:26:28: Express Scripts’ new formulary ejects some drugs once thought 'untouchable': analysts

Fri, 10 Aug 2018 14:03:09: Pfizer's Besponsa, Lilly's Taltz rack up reimbursement wins at NICE

Fri, 10 Aug 2018 13:16:52: Amid pricing spat with U.K. government, Vertex won't ask NICE to approve its new CF drug

Fri, 10 Aug 2018 04:32:06: FiercePharmaAsia—Lenvima growth; China’s drug invite; Samsung’s biologics commitment

Thu, 09 Aug 2018 19:02:48: Step therapy changes at Medicare Part B to hit Amgen, Regeneron particularly hard: analysts

Thu, 09 Aug 2018 15:21:54: Can a strategic review solve Mylan's problems? Don't count on it

Thu, 09 Aug 2018 15:11:25: Bausch Health aims top-seller Xifaxan at new diseases to pump up growth

Thu, 09 Aug 2018 14:44:46: FDA approves first generic under new pathway designed to fight drug price gouging

Thu, 09 Aug 2018 13:33:39: Mylan says plant remediation dictated in part by which generics to drop

Thu, 09 Aug 2018 13:28:15: Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi

Thu, 09 Aug 2018 13:24:22: Struggling Perrigo OKs plan to hive off prescription business

Thu, 09 Aug 2018 13:21:56: China targets Cosentyx, Shingrix and Luxturna and 45 other drugs for priority approval